Shengtai Pharmaceutical Inc., (OTC BB: SGTI) is China’s leading manufacturer and supplier of pharmaceutical grade glucose for medicinal purposes. In addition to their pharmaceutical glucose series of products, they also produce other medicinal product lines as well such as industrial glucose, syrup, starch, avermectins, dextrin, maltose and maltitol, which are used for food, beverage and industrial production. Based in China, Shengtai has an international client-base. For further information, visit the company website at: www.shengtaipharmaceutical.com.
- 17 years ago
QualityStocks
Shengtai Pharmaceutical Inc., (OTC BB: SGTI)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Leveraging MCO Success to Elevate Portfolio Clubs to the International Stage
Brera Holdings (NASDAQ: BREA), an Ireland-based company focused on expanding a global portfolio of men’s…
-
QualityStocksNewsBreaks – Why Silvercorp Metals Inc. (NYSE American: SVM) (TSX: SVM) Is ‘One to Watch’
Silvercorp Metals (NYSE American: SVM) (TSX: SVM) is a Canadian mining company with a strong track…
-
Nutriband Inc. (NASDAQ: NTRB) Reimagining Drug Safety Through Scalable Innovation
Nutriband Inc. has been granted a new U.S. patent for its AVERSA(TM) transdermal abuse-deterrent technology,…